Journal Article Review Epublish 34 citations
PubMed: 36570532 DOI: 10.3389/fnagi.2022.1077384
Post-COVID-19 human memory impairment: A PRISMA-based systematic review of evidence from brain imaging studies.
Front Aging Neurosci 14:1077384
Authors: Dan Shan, Shaoyang Li, Ruichen Xu, Glen Nie, Yangyiran Xie, Junchu Han, Xiaoyi Gao, Yuandian Zheng, Zhen Xu, Zhihao Dai
Affiliations
- Department of Biobehavioral Sciences, Columbia University, New York, NY, United States.
- Faculty of Science, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.
- Department of Integrative Biology, University of Wisconsin-Madison, Madison, WI, United States.
- Department of Biological Science, Northeastern University, Boston, MA, United States.
- School of Medicine, Vanderbilt University, Nashville, TN, United States.
- New York State Psychiatric Institute, Global Psychiatric Epidemiology Group, New York, NY, United States.
- School of Medicine, Saint Louis University, St. Louis, MO, United States.
- Minhang Crosspoint Academy at Shanghai Wenqi Middle School, Shanghai, China.
- School of Medicine, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland.
Abstract
Many people with coronavirus disease 2019 (COVID-19) report varying degrees of memory impairment. Neuroimaging techniques such as MRI and PET have been utilized to shed light on how COVID-19 affects brain function in humans, including memory dysfunction. In this PRISMA-based systematic review, we compared and summarized the current literature looking at the relationship between COVID-19-induced neuropathological changes by neuroimaging scans and memory symptoms experienced by patients who recovered from COVID-19. Overall, this review suggests a correlational trend between structural abnormalities (e.g., cortical atrophy and white matter hyperintensities) or functional abnormalities (e.g., hypometabolism) in a wide range of brain regions (particularly in the frontal, parietal and temporal regions) and memory impairments in COVID-19 survivors, although a causal relationship between them remains elusive in the absence of sufficient caution. Further longitudinal investigations, particularly controlled studies combined with correlational analyses, are needed to provide additional evidence.
MeSH
Brain, Memory, Neuroimaging, Covid-19
Cited by
- Immunoglobulin A as a Key Immunological Molecular Signature of Post-COVID-19 Conditions. Viruses, 2023
- Long COVID prevalence and impact on quality of life 2Â years after acute COVID-19. Sci Rep, 2023
- Neuroimmune pathophysiology of long COVID. Psychiatry Clin Neurosci, 2025
- Advanced magnetic resonance neuroimaging techniques: feasibility and applications in long or post-COVID-19 syndrome - a review. Ann Med Surg (Lond), 2024
- Health Resort Treatment Mitigates Neuropsychiatric Symptoms in Long COVID Patients: A Retrospective Study. Healthcare (Basel), 2025
- Subjective attitudes moderate the social connectedness in esports gaming during COVID-19 pandemic: A cross-sectional study. Front Public Health, 2023
- Association between COVID-19 infection and new-onset dementia in older adults: a systematic review and meta-analysis. BMC Geriatr, 2024
- Infarct volume as a predictor and therapeutic target in post-stroke cognitive impairment. Front Med (Lausanne), 2025
- Evaluating the Predictors of Persistent Long COVID Symptoms and Their Severity in COVID-19 Survivors 1 Year After Infection. J Prim Care Community Health, 2024
- The relationship between cognitive function and neuropsychiatric disorders with quantitative electroencephalogram (qEEG) on long COVID syndrome patients. Brain Behav Immun Health, 2025
- Cognitive function and quantitative electroencephalogram analysis in subjects recovered from COVID-19 infection. BMC Neurol, 2024
- Characterization of cognitive symptoms in post COVID-19 patients. Eur Arch Psychiatry Clin Neurosci, 2024
- Importance of Magnesium Status in COVID-19. Biology (Basel), 2023
- Structural and functional neuroimaging of hippocampus to study adult neurogenesis in long COVID-19 patients with neuropsychiatric symptoms: a scoping review. PeerJ, 2025
- Cognitive Decline in Patients With Trigeminal Neuralgia: A Resting-State fMRI Study. Brain Behav, 2025
- Neurexin dysfunction in neurodevelopmental and neuropsychiatric disorders: a PRIMSA-based systematic review through iPSC and animal models. Front Behav Neurosci, 2024